Avita Medical Ltd
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more
Avita Medical Ltd (RCEL) - Net Assets
Latest net assets as of December 2025: $-16.65 Million USD
Based on the latest financial reports, Avita Medical Ltd (RCEL) has net assets worth $-16.65 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($56.39 Million) and total liabilities ($73.04 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-16.65 Million |
| % of Total Assets | -29.53% |
| Annual Growth Rate | N/A |
| 5-Year Change | -115.91% |
| 10-Year Change | -342.98% |
| Growth Volatility | 131.06 |
Avita Medical Ltd - Net Assets Trend (1993–2025)
This chart illustrates how Avita Medical Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Avita Medical Ltd (1993–2025)
The table below shows the annual net assets of Avita Medical Ltd from 1993 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-16.65 Million | -470.08% |
| 2024-12-31 | $4.50 Million | -90.83% |
| 2023-12-31 | $49.06 Million | -42.11% |
| 2022-12-31 | $84.74 Million | -19.01% |
| 2021-12-31 | $104.62 Million | +44.51% |
| 2020-12-31 | $72.40 Million | +247.55% |
| 2019-12-31 | $20.83 Million | +9.72% |
| 2017-12-31 | $18.99 Million | +270.71% |
| 2016-12-31 | $5.12 Million | -25.26% |
| 2015-12-31 | $6.85 Million | +62.50% |
| 2014-12-31 | $4.22 Million | -23.70% |
| 2013-12-31 | $5.53 Million | -47.14% |
| 2012-12-31 | $10.46 Million | +22.23% |
| 2011-12-31 | $8.55 Million | -49.65% |
| 2010-12-31 | $16.99 Million | +327.31% |
| 2009-12-31 | $3.98 Million | -42.65% |
| 2008-12-31 | $6.93 Million | -46.50% |
| 2007-12-31 | $12.96 Million | +18.06% |
| 2006-12-31 | $10.98 Million | -1.54% |
| 2005-12-31 | $11.15 Million | -14.85% |
| 2004-12-31 | $13.09 Million | +51.23% |
| 2003-12-31 | $8.66 Million | +4.99% |
| 2002-12-31 | $8.25 Million | +81.93% |
| 2001-12-31 | $4.53 Million | -15.78% |
| 2000-12-31 | $5.38 Million | +98.01% |
| 1999-12-31 | $2.72 Million | +146.17% |
| 1998-12-31 | $1.10 Million | -37.92% |
| 1997-12-31 | $1.78 Million | -64.28% |
| 1996-12-31 | $4.98 Million | +11.06% |
| 1995-12-31 | $4.48 Million | -22.94% |
| 1994-12-31 | $5.82 Million | -11.16% |
| 1993-12-31 | $6.55 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Avita Medical Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 40747445949.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Comprehensive Income | $-1.37 Million | % |
| Other Components | $394.41 Million | % |
| Total Equity | $-16.65 Million | 100.00% |
Avita Medical Ltd Competitors by Market Cap
The table below lists competitors of Avita Medical Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Global Standard Technology Limited
KQ:083450
|
$135.39 Million |
|
Vinte Viviendas Integrales S.A.B. de C.V
MX:VINTE
|
$135.41 Million |
|
Open Orphan plc
PINK:OPORF
|
$135.41 Million |
|
OrganiGram Holdings Inc
NASDAQ:OGI
|
$135.42 Million |
|
Hi-Lex Corporation
PINK:HLXFF
|
$135.36 Million |
|
ZYF Lopsking Aluminum Co Ltd
SHE:002333
|
$135.36 Million |
|
MYT Netherlands Parent BV
NYSE:MYTE
|
$135.34 Million |
|
Troilus Gold Corp
OTCQX:CHXMF
|
$135.30 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Avita Medical Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 4,499,000 to -16,650,000, a change of -21,149,000 (-470.1%).
- Net loss of 48,587,000 reduced equity.
- New share issuances of 14,792,000 increased equity.
- Other comprehensive income increased equity by 572,000.
- Other factors increased equity by 12,074,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-48.59 Million | -291.81% |
| Share Issuances | $14.79 Million | +88.84% |
| Other Comprehensive Income | $572.00K | +3.44% |
| Other Changes | $12.07 Million | +72.52% |
| Total Change | $- | -470.08% |
Book Value vs Market Value Analysis
This analysis compares Avita Medical Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1993-12-31 | $146.96 | $4.47 | x |
| 1994-12-31 | $126.40 | $4.47 | x |
| 1995-12-31 | $95.11 | $4.47 | x |
| 1996-12-31 | $105.63 | $4.47 | x |
| 1997-12-31 | $37.73 | $4.47 | x |
| 1998-12-31 | $4.42 | $4.47 | x |
| 1999-12-31 | $4.96 | $4.47 | x |
| 2000-12-31 | $2.70 | $4.47 | x |
| 2001-12-31 | $2.28 | $4.47 | x |
| 2002-12-31 | $10.23 | $4.47 | x |
| 2003-12-31 | $5.45 | $4.47 | x |
| 2004-12-31 | $0.34 | $4.47 | x |
| 2005-12-31 | $4.31 | $4.47 | x |
| 2006-12-31 | $2.78 | $4.47 | x |
| 2007-12-31 | $18.34 | $4.47 | x |
| 2008-12-31 | $6.28 | $4.47 | x |
| 2009-12-31 | $3.12 | $4.47 | x |
| 2010-12-31 | $9.22 | $4.47 | x |
| 2011-12-31 | $3.59 | $4.47 | x |
| 2012-12-31 | $3.48 | $4.47 | x |
| 2013-12-31 | $1.70 | $4.47 | x |
| 2014-12-31 | $1.19 | $4.47 | x |
| 2015-12-31 | $1.37 | $4.47 | x |
| 2016-12-31 | $0.76 | $4.47 | x |
| 2017-12-31 | $2.04 | $4.47 | x |
| 2019-12-31 | $0.93 | $4.47 | x |
| 2020-12-31 | $3.57 | $4.47 | x |
| 2021-12-31 | $4.30 | $4.47 | x |
| 2022-12-31 | $3.39 | $4.47 | x |
| 2023-12-31 | $1.94 | $4.47 | x |
| 2024-12-31 | $0.17 | $4.47 | x |
| 2025-12-31 | $-0.60 | $4.47 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Avita Medical Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -67.85%
- • Asset Turnover: 1.27x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-109.45%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1993 | -3.44% | 0.00% | 0.00x | 1.06x | $-880.28K |
| 1994 | -33.31% | 0.00% | 0.00x | 1.04x | $-2.52 Million |
| 1995 | -28.68% | 0.00% | 0.00x | 1.02x | $-1.73 Million |
| 1996 | 3.70% | 0.00% | 0.00x | 1.01x | $-313.45K |
| 1997 | -128.74% | 0.00% | 0.00x | 1.01x | $-2.47 Million |
| 1998 | -50.98% | -96.55% | 0.52x | 1.02x | $-673.26K |
| 1999 | -26.67% | 0.00% | 0.00x | 0.92x | $-1.12 Million |
| 2000 | -29.48% | 0.00% | 0.00x | 1.04x | $-2.06 Million |
| 2001 | -24.66% | 0.00% | 0.00x | 1.11x | $-1.58 Million |
| 2002 | -18.73% | -794.76% | 0.02x | 1.04x | $-2.37 Million |
| 2003 | -57.57% | -1281.08% | 0.04x | 1.06x | $-5.85 Million |
| 2004 | -54.39% | -988.65% | 0.05x | 1.11x | $-8.43 Million |
| 2005 | -79.70% | -1005.81% | 0.07x | 1.17x | $-10.00 Million |
| 2006 | -116.42% | -1615.42% | 0.07x | 1.10x | $-13.88 Million |
| 2007 | -89.99% | -968.80% | 0.08x | 1.20x | $-12.96 Million |
| 2008 | -59.70% | -174.86% | 0.30x | 1.14x | $-4.83 Million |
| 2009 | -125.89% | -217.95% | 0.29x | 1.98x | $-5.40 Million |
| 2010 | -12.28% | -62.54% | 0.18x | 1.10x | $-3.78 Million |
| 2011 | -88.73% | -226.42% | 0.31x | 1.25x | $-8.45 Million |
| 2012 | -77.41% | -287.49% | 0.22x | 1.23x | $-9.14 Million |
| 2013 | -93.14% | -191.84% | 0.37x | 1.32x | $-5.70 Million |
| 2014 | -186.55% | -798.10% | 0.18x | 1.29x | $-8.29 Million |
| 2015 | -149.90% | -1025.14% | 0.12x | 1.26x | $-10.96 Million |
| 2016 | -224.74% | -974.99% | 0.15x | 1.50x | $-12.02 Million |
| 2017 | -90.62% | -1370.83% | 0.05x | 1.21x | $-19.10 Million |
| 2019 | -118.20% | -456.31% | 0.21x | 1.24x | $-26.71 Million |
| 2020 | -34.01% | -456.31% | 0.07x | 1.14x | $-31.86 Million |
| 2021 | -24.03% | -76.13% | 0.28x | 1.11x | $-35.60 Million |
| 2022 | -31.47% | -77.47% | 0.35x | 1.16x | $-35.14 Million |
| 2023 | -72.12% | -70.56% | 0.45x | 2.28x | $-40.29 Million |
| 2024 | -1374.64% | -96.26% | 0.81x | 17.72x | $-62.29 Million |
| 2025 | 0.00% | -67.85% | 1.27x | 0.00x | $-46.92 Million |
Industry Comparison
This section compares Avita Medical Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Avita Medical Ltd (RCEL) | $-16.65 Million | -3.44% | N/A | $135.36 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |